Target List
Angioimmunoblastic T Cell Lymphomas
Burkitt Lymphomas
Diffuse Large B Cell Lymphomas (DLBCL)
ALKBCL11ABCL6CCND3CIITACLTCIGLL5MAPK13MYCNPM1PIM1RELSQSTM1TBL1XR1TOMM40TP63ALKAMER1APCARID1AASXL1ATMB2MBCL2BCORBRAFBTKCD79BCDKN2ACNOT3CREBBPCTNNB1CXCR4DNMT3AEZH2FBXW7HLA-AID3IDH2IRS4JAK1JAK3KITKMT2DKRASMAP2K1MED12MSNMYCMYD88NCOR1NFKBIENOTCH2NRASNSD2PAX5PIK3CAPIK3R1PLCG1POT1PPM1DPTENRGS7RHOASF3B1SMOSRSF2STAT3STAT5BSTAT6TERTTRRAPWT1XPO1ZFHX3ZNF479
Follicular Lymphomas
Hodgkin Lymphomas
Mantle Cell Lymphomas
Peripheral T Cell Lymphomas
Other Lymphomas
Commercial Control Samples
Checkpoint Molecules
Checkpoint Blockade Therapy Biomarkers
Immune Cell Markers
Regulatory T Cells
Myeloid Derived Suppressor Cells
Plasmacytoid Dendritic Cells
Antigen Presenting Cells
T Cell Trafficking & Infiltration into Tumors
T Cell Exhaustion
Downregulated in T Cell Exhaustion
Responsiveness or Response Biomarkers
Regulated during Treatment
Pre-Treatment Response Prediction
Cancer Cell Killing
Stimulates Cancer Cell Killing
Antigen Processing & Presentation
Proteases
Interferon Gamma Response
RNA Degradation
Expression Altered due to Genetic Alterations
AIDS-Related Lymphomas
B Cell Lymphomas
Small Lymphocytic Lymphomas
Enteropathy-Type T Cell Lymphomas
Marginal Zone Lymphomas
Mycosis Fungoides (Sezary Syndrome)
NK-T Cell Lymphomas
Primary Central Nervous System Lymphomas